Is NF-kappaB a culprit in type 2 diabetes? (Q23912824)

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

PPARgamma in monocytes: less pain, any gain?

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Obesity and the regulation of energy balance

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Insulin signalling and the regulation of glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

New drug targets for type 2 diabetes and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

A central role for JNK in obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

IKK-beta links inflammation to obesity-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

New insights into the role of nuclear factor-KB, a ubiquitous transcription factor in the initiation of diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Severe liver degeneration in mice lacking the IkappaB kinase 2 gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Inhibition of NF-kappa B by sodium salicylate and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

A kinase in the life of the beta cell

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Nuclear Factor κB Protects Pancreatic β-Cells From Tumor Necrosis Factor-α-Mediated Apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021

Nuclear factor-{kappa}B activity in {beta}-cells is required for glucose-stimulated insulin secretion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.03.075

7 January 2021